Skip to content
Recall Observatory FDA recall evidence

Drug product

Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703, USA. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India NDC 16729-472-08 (Vial NDC 16729-472-30)

D-0250-2021

January 28, 2021

Class III

Product summary

Firm
Accord Healthcare, Inc.
Event
Event 87233
Status
Terminated
Classification
Class III
Quantity
502 cartons
Official record key
drug-enforcement:D-0250-2021

Official wording

Reason: Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials

Code information: Lot: M2013645 Exp. Aug. 2022

Distribution pattern: Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling; Label Mix-up